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BACKGROUND: Distal left main (LM) coronary artery bifurcation disease 
increases percutaneous coronary intervention (PCI) procedural complexity 
and is associated with worse outcomes than isolated ostial/shaft disease. 
The optimal treatment strategy for distal LM disease is undetermined. We 
sought to determine whether outcomes after PCI of LM distal bifurcation 
lesions are influenced by treatment with a provisional 1-stent versus planned 
2-stent technique, and if so, whether such differences are conditioned by the 
complexity of the LM bifurcation lesion.
METHODS AND RESULTS: The clinical and angiographic characteristics, 
procedural methods and outcomes, and clinical events through 3-year follow-up 
were compared in patients undergoing distal LM PCI with a 1-stent provisional 
versus planned 2-stent technique in the EXCEL trial (Evaluation of XIENCE Versus 
Coronary Artery Bypass Surgery for Effectiveness of Left Main Revascularization). 
Among 529 patients undergoing planned distal LM PCI, 344 (65.0%) and 185 
(35.0%) were treated with intended 1-stent provisional and planned 2-stent 
techniques, respectively. The primary composite end point rate of death, 
myocardial infarction, or stroke at 3 years was significantly lower in patients 
treated with the provisional 1-stent versus planned 2-stent method (14.1% 
versus 20.7%; adjusted hazard ratio, 0.55; 95% CI, 0.35–0.88; P=0.01), 
driven by differences in cardiovascular death (3.3% versus 8.3%, P=0.01) and 
myocardial infarction (7.7% versus 12.8%, P=0.06). The 3-year rate of ischemia-
driven revascularization of the LM complex was also lower in the provisional 
group (7.2% versus 16.3%, P=0.001). In 342 patients with distal LM bifurcation 
disease that did not involve both major side branch vessels, the 3-year primary 
end point was lower with a provisional 1-stent versus planned 2-stent technique 
(13.8% versus 23.3%, P=0.04), whereas no significant difference was present in 
182 patients with distal LM bifurcation disease that did involve both side branch 
vessels (14.3% versus 19.2%, P=0.36).
CONCLUSIONS: Among patients with distal LM bifurcation disease in the 
EXCEL trial randomized to PCI, 3-year adverse outcomes were worse with 
planned 2-stent treatment compared with a provisional 1-stent approach, a 
difference that was confined to patients without major involvement of both 
LM side branch vessels.
CLINICAL TRIAL REGISTRATION: URL: https://www.clinicaltrials.gov. Unique 
identifier: NCT01205776.
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Recent comparative studies of percutaneous and surgical revascularization for unprotected left main (LM) coronary artery disease have demon-
strated clinical equipoise between the 2 revasculariza-
tion modalities about the major outcomes of death, 
myocardial infarction (MI), and stroke.1,2 On the basis 
of these results, percutaneous coronary intervention 
(PCI) may be considered an alternative to bypass sur-
gery for selected patients with unprotected LM dis-
ease. However, the clinical outcomes of PCI may vary 
according to LM lesion site and complexity. Specifically, 
disease of the distal LM bifurcation increases PCI pro-
cedural complexity and is associated with worse clinical 
outcomes compared with disease limited to the LM 
ostial and shaft segments.3,4 The optimal interventional 
approach when the distal LM bifurcation is involved 
remains uncertain, and although most non-LM bifurca-
tion PCI studies have endorsed a provisional treatment 
strategy,5–8 ≈40% of LM interventions are performed 
with an intentional 2-stent approach.9–12 The wide 
variability in LM anatomy, coupled with differences in 
stent types, techniques, and operator expertise repre-
sented in prior studies have precluded reaching uniform 
recommendations as to the best stenting strategy for 
LM distal bifurcation disease. We therefore examined 
procedural methods and outcomes among patients 
undergoing distal LM PCI in the EXCEL trial (Evaluation 
of XIENCE Versus Coronary Artery Bypass Surgery for 
Effectiveness of Left Main Revascularization).13
METHODS
Trial and Study Population
The design, enrollment criteria, and methods of the EXCEL 
trial have been previously reported.14 EXCEL was an interna-
tional, large-scale, open-label, multicenter trial in which 1905 
patients with LM disease and low or intermediate SYNTAX 
scores (≤32) eligible for both PCI and coronary artery bypass 
surgery as assessed by a site-based heart team were random-
ized to treatment with cobalt-chromium alloy fluoropolymer-
based everolimus-eluting stents (XIENCE; Abbott Vascular, 
Santa Clara, CA) or bypass graft surgery. The study was 
approved by the institutional review board or ethics committee 
at each enrolling site, and consecutive, eligible patients signed 
written informed consent before the revascularization assign-
ment. At the time of the present report, the 3-year follow-up 
time point has been reached for all randomized patients.
Whether a 1-stent provisional approach or planned 2-stent 
approach to distal LM bifurcation disease was undertaken 
was left to the discretion of the operator. In patients under-
going a provisional approach, the decision to predilate and 
postdilate the side branch (usually the left circumflex coronary 
artery [LCX]) was left to operator discretion. If side branch 
postdilatation was required, the protocol recommended 
implanting a second stent if, after a kissing balloon inflation, 
either a severe dissection (≥grade B), thrombolysis in myo-
cardial infarction flow <3, or a severe stenosis was present 
(>70% angiographic diameter stenosis [DS], minimal luminal 
area by intravascular ultrasound ≤4.0 mm2 with plaque bur-
den >60%, or fractional flow reserve ≤0.80). Proximal optimi-
zation and kissing balloon inflations were recommended for 
both techniques.
Study End Points and Data Management
The primary end point was the composite rate of death, MI, 
or stroke at a median follow-up period of 3 years. Major 
secondary end points included death, MI, or stroke at 30 
days, and the composite rate of death, MI, stroke, or isch-
emia-driven revascularization (IDR) at a median follow-up 
of 3 years. Study end point definitions and qualifying crite-
ria have been previously described.14 The case report form 
collected site-assessed stenosis severity and location within 
WHAT IS KNOWN
• Among patients undergoing distal left main (LM) 
bifurcation percutaneous coronary intervention 
in the EXCEL trial (Evaluation of XIENCE Versus 
Coronary Artery Bypass Surgery for Effectiveness of 
Left Main Revascularization), important differences 
in bifurcation anatomy, procedural methods, and 
outcomes were observed in those treated with a 
provisional 1-stent versus a planned 2-stent strategy.
• Although early outcomes were similar with the 
1-stent provisional and planned 2-stent tech-
niques, at 3-year follow-up, the rates of cardiovas-
cular death, myocardial infarction, ischemia-driven 
revascularization of the LM complex, and the 
composite primary end point of death, myocardial 
infarction, or stroke were more common with a 
planned 2-stent strategy, differences that persisted 
after multivariable adjustment for differences in 
clinical risk factors and coronary anatomy.
• These outcomes were importantly conditioned by 
whether both major side branches of the distal LM 
bifurcation were or were not involved.
WHAT THE STUDY ADDS
• With the wide variability in LM anatomy and dis-
ease distribution, as well as differences in stent 
types, technique, and operator expertise, no uni-
form recommendation about the best stenting 
strategy for LM distal bifurcation disease has pre-
vailed. In this analysis, 3-year adverse outcomes 
were worse with planned 2-stent treatment com-
pared with a provisional 1-stent approach, a differ-
ence that was confined to patients without major 
involvement of both LM side branch vessels.
• These results not only inform procedural technique 
about LM percutaneous coronary intervention but 
also advance our understanding of outcomes after 
LM percutaneous coronary intervention relative to 
treatment strategies.
• Especially in 2-stent strategies, further comparative 
study is needed to refine technique and outcomes 
in complex distal LM bifurcation disease.
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the different regions of the LM and in cases in which the 
distal LM bifurcation was involved (>50% visually assessed 
DS), whether the intent was to use a planned provisional 
1-stent technique (with implantation of a second bailout 
stent reserved for a suboptimal result in the side branch) or a 
planned routine 2-stent technique. Details of crossover pro-
cedures and 2-stent methods were also collected.
All data were submitted to a central data coordinating 
facility (Cardiovascular Research Foundation, New York, NY). 
An independent clinical events committee adjudicated all pri-
mary and secondary end points after review of original source 
documents. Coronary angiograms performed at baseline were 
reviewed by an independent core laboratory (Cardiovascular 
Research Foundation). The data, analytic methods, and study 
materials are proprietary to the sponsor and will not be made 
available to other researchers for purposes of reproducing the 
results or replicating the procedure.
Statistical Methods
The present analysis was prespecified in the original study 
protocol. All patients with site-assessed distal LM bifurcation 
disease randomized to and treated with PCI were included, 
and patient groups were compared according to intended 
treatment using a planned 1-stent provisional technique 
(regardless as to whether a second stent was implanted) or 
routine 2-stent method. To examine whether the complexity 
of the distal LM bifurcation lesion impacted the outcomes of 
the planned 1-stent provisional versus routine 2-stent tech-
nique, the treatment groups were also compared according 
to whether both side branches had an ostial lesion (within 
3 mm of the distal LM bifurcation) with DS ≥50% by angio-
graphic core laboratory analysis.
Baseline characteristics of study patients were summa-
rized in terms of frequencies and percentages for categori-
cal variables and by means with SD for continuous variables. 
Categorical variables were compared by χ2 or Fisher exact 
test if >20% of the expected cell frequencies were <5. For 
continuous variables that met the assumption of normality 
by the Shapiro–Wilk test, the 2 treatment groups were com-
pared by the 2-sample t test. If the data failed to meet the 
assumption for normality, comparisons were made using the 
Wilcoxon rank-sum test. Three-year clinical events were sum-
marized as Kaplan-Meier estimates and compared with the 
log-rank test. Hazard ratios and 95% CI were determined 
using Cox proportional hazards models. Multivariable analy-
sis was performed using Cox stepwise regression to adjust 
for the influence of potential confounders on the relationship 
between planned technique and composite adverse events at 
3 years. The list of covariates used included age, male sex, 
recent MI (<7 days), current smoker, diabetes mellitus, cre-
atinine clearance <60 mL/min, SYNTAX score, concomitant 
LM ostial or shaft DS >50%, worst LM %DS, ostial left ante-
rior descending [LAD] %DS, ostial LCX %DS, thrombolysis 
in myocardial infarction flow <3 in either the LAD or LCX, 
and left ventricular ejection fraction. Angiographic measures 
included in the model were determined by angiographic core 
laboratory assessment. A 2-sided P value of 0.05 was estab-
lished as the level of statistical significance for all superiority 
tests. All analyses were performed with SAS software version 
9.4 (SAS Institute, Cary, NC).
RESULTS
Clinical and Angiographic Characteristics
PCI was the first procedure performed in 935 of 
the 948 patients randomized to PCI. Site-reported 
planned distal LM bifurcation PCI was performed in 
529 of 925 patients (57.2%); in 10 additional cases, 
the procedural strategy was not recorded. Among the 
529 patients with planned distal LM bifurcation dis-
ease, 344 patients (65.0%) were treated with a pro-
visional 1-stent technique, and 185 patients (35.0%) 
underwent planned 2-stent bifurcation PCI. No signif-
icant differences were present in the baseline clinical 
or demographic characteristics between the groups 
other than a greater incidence of stable angina in the 
provisional 1-stent group (Table  1). Approximately 
one-third of patients had diabetes mellitus, and 
≈40% of patients presented with unstable angina or 
recent MI.
Both the prevalence of non-LM disease and site-
assessed SYNTAX score were similar between the 
provisional 1-stent and planned 2-stent treatment 
groups (Table  1); however, by angiographic core 
laboratory analysis, the overall SYNTAX score was 
significantly higher among patients in the planned 
2-stent group. Similarly, patients undergoing planned 
2-stent treatment were more likely to have distal 
LM bifurcation disease involving both the ostial LAD 
and ostial LCX coronary segments (Medina classifica-
tion 1,1,1 or 0,1,1 by angiographic core laboratory 
analysis). Side branch lesion length (4.7±3.4 versus 
8.8±7.6 mm, P<0.0001) and %DS (34.3±22.9% ver-
sus 59.7±22.3%, P<0.0001) were also significantly 
greater among planned 2-stent cases. No significant 
difference in the bifurcation angle separating the 
LAD and LCX was observed between the provisional 
1-stent and planned 2-stent groups.
Procedural Outcomes
Radial artery access and 6F guiding catheters were used 
more frequently for provisional 1-stent procedures, 
whereas femoral artery access and 8F guiding catheter 
use were more common among planned 2-stent cases 
(Table 2). Despite significantly greater use of hemody-
namic support devices with the planned 2-stent tech-
nique, site-reported procedural complications did not 
differ between treatment strategies. Planned 2-stent 
treatment was associated with longer procedural dura-
tion compared with a provisional method but with simi-
lar contrast utilization.
Among the 344 patients undergoing a planned 
provisional 1-stent method, treatment of the side 
branch was performed frequently (70.6%), most com-
monly with balloon angioplasty alone (Table 2). Rescue 
or bailout stenting of the side branch was required 
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Table 1. Baseline Clinical and Angiographic Characteristics According to the Planned Stent Approach in 
Patients With Left Main Distal Bifurcation Disease
 
Provisional 1-Stent 
(n=344)
Planned 2-Stent 
(n=185) P Value
Clinical characteristics
  Age, y 66.2±9.3 66.8±9.3 0.54
  Male sex 275 (79.9) 141 (76.2) 0.32
  Diabetes mellitus 99 (28.8) 64 (34.6) 0.17
  Smoking history 221 (64.8) 118 (64.1) 0.88
  Hypertension 254 (73.8) 141 (76.2) 0.55
  Hyperlipidemia 251 (73.0) 129 (70.1) 0.49
  Prior myocardial infarction 65 (19.2) 38 (20.8) 0.66
  Prior percutaneous coronary intervention 69 (20.1) 42 (22.8) 0.46
  Prior stroke or transient ischemic attack 16 (4.7) 15 (8.1) 0.11
  Left ventricular ejection fraction, % 57.5±9.4 56.1±10.1 0.27
  Clinical presentation   0.13
   Stable angina 198 (57.9) 87 (47.3)  
   Unstable angina 74 (21.6) 46 (25.0)  
   Recent myocardial infarction* 50 (14.6) 36 (19.6)  
Angiographic characteristics
  Site assessed    
   SYNTAX score, site assessed 21.2±6.1 22.2±5.8 0.07
   SYNTAX score, categories   0.10
    0–22 (low) 191 (55.5) 89 (48.1)  
    23–32 (intermediate) 153 (44.5) 96 (51.9)  
   LM ostial or shaft stenosis ≥50% 161 (47.9) 65 (37.1) 0.02
   Ostial anterior descending artery ≥50% 170 (49.4) 126 (68.1) <0.0001
   Ostial left circumflex artery ≥50% 121 (35.2) 140 (75.7) <0.0001
   Angle between LAD and LCX, ° 84.7±21.6 86.8±22.4 0.18
   LM disease only 51 (14.8) 25 (13.5) 0.68
   LM and 1-vessel disease 106 (30.8) 50 (27.0) 0.36
   LM and 2-vessel disease 117 (34.0) 63 (34.1) 0.99
   LM and 3-vessel disease 66 (19.2) 43 (23.2) 0.27
 Angiographic core laboratory-assessed
   SYNTAX score (continuous) 27.8±8.8 30.7±8.7 0.0008
   SYNTAX score   0.005
    0–22 (low) 99/340 (29.1) 31/179 (17.3)  
    23–32 (intermediate) 146/340 (42.9) 79/179 (44.1)  
    ≥33 (high) 95/340 (27.9) 69/179 (38.5)  
   Medina classification†   <0.0001
    1,0,0 65/210 (31.0) 9/118 (7.6)  
    0,1,0 9/210 (4.3) 3/118 (2.5)  
    1,1,0 63/210 (30.0) 13/118 (11.0)  
    0,0,1 0/210 (0) 2/118 (1.7)  
    1,0,1 26/210 (12.4) 22/118 (18.6)  
    0,1,1 1/210 (0.5) 5/118 (4.2)  
    1,1,1 45/210 (21.4) 64/118 (54.2)  
   LM trifurcation disease present† 122/344 (35.5) 61/185 (33.0)  
Values are n/N (%) or mean±SD. LAD indicates left anterior descending coronary artery; LCX, left circumflex coronary 
artery; and LM, left main coronary artery.
*Within 7 days before randomization.
†Required diameter stenosis ≥50% by core laboratory measurement.
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in 54 (15.7%) of all provisional 1-stent procedures. 
T-stenting, modified T-stenting, and T-stent and protru-
sion were the most commonly used techniques in such 
bailout stent cases, as well as in the majority of the 185 
intended 2-stent strategies, followed by culotte and 
crush techniques (Table 2).
Clinical Outcomes
Adverse event rates within 30 days were not statis-
tically different between the 2 groups (Table  3). At 3 
years, however, the primary end point of death, MI, or 
stroke occurred in significantly fewer patients treated 
with the provisional 1-stent approach compared with 
Table 2. Procedural Characteristics According to the Planned Stent Approach in Patients With Left Main 
Distal Bifurcation Disease
 
Provisional 1-Stent 
(344 Patients, 376 
Procedures*)
Provisional 1-Stent 
(185 Patients, 208 
Procedures*) P Value
Maximum LM device diameter, mm 4.07±0.52 3.95±0.48 0.01
Poststent dilation 311/344 (90.4) 173/185 (93.5) 0.22
Guiding catheter size <0.0001
  6F 169/344 (49.1) 54/185 (29.1)  
  7F 134/344 (39.0) 79/185 (42.7)  
  8F 41/344 (11.9) 52/185 (28.1)  
Radial artery access 135/376 (35.9) 38/208 (18.3) <0.0001
Intravascular ultrasound used 266/344 (77.3) 139/185 (75.1) 0.57
Fractional flow reserve used 31/344 (9.0) 14/185 (7.6) 0.57
Rotational atherectomy performed 24/344 (7.0) 11/185 (5.9) 0.65
Hemodynamic support used 12/375 (3.2) 21/208 (10.1) 0.0006
Unfractionated heparin used 317/373 (85.0) 160/206 (77.6) 0.03
Bivalirudin used 94/373 (25.2) 74/206 (35.9) 0.006
GP IIb/IIIa inhibitor used 28/376 (7.4) 18/208 (8.7) 0.60
Contrast volume, mL 264±131 270±122 0.30
Fluoroscopy time, min 24±15 28±17 0.0004
Procedural complications† 42/376 (11.2) 29/208 (13.9) 0.33
Provisional 1-stent approach
  Side branch treatment, any 243/344 (70.6) … …
   Balloon angioplasty 207/243 (85.2) … …
   Atherectomy 5/243 (2.1) … …
   Stent 54/243 (22.2) … …
  Side branch stent technique  … …
   T, modified T, or TAP 42/54 (77.8) … …
   Culotte or reverse crush 8/54 (14.8) … …
   Other 4/54 (7.4) … …
Planned 2-stent approach
  T, modified T, or TAP … 92/185 (50.8) …
  Culotte … 42/185 (23.2) …
  Crush or mini-crush … 26/185 (14.4) …
  V stent … 11/185 (6.1) …
  Simultaneous kissing stents … 5/185 (2.8) …
  Other … 5/185 (2.8) …
Final kissing balloon inflation 189/344 (54.9) 156/185 (84.3) <0.0001
Residual SYNTAX Score 7.0±6.9 6.3±6.5 0.39
Values are n/N (%) or mean±SD. GP indicates glycoprotein; LM, left main coronary artery; and TAP, T and protrusion.
*Includes staged procedures.
†Defined as chest pain or ECG changes lasting >10 min, slow flow, no reflow, distal embolization, abrupt closure, 
perforation, dissection, stent thrombosis, tamponade, cardiac arrest, stroke, bleeding, or severe arrhythmias.
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the planned 2-stent technique (14.1% versus 20.7%; 
multivariable-adjusted hazard ratio, 0.55; 95% CI, 
0.35–0.88; P=0.01; Tables 3 and 4, and Figure 1A). The 
3-year rate of IDR of the LM complex was also lower in 
the provisional group, as was the composite end point 
of death, MI, stroke, or IDR (Figure 1B). Definite or prob-
able stent thrombosis occurred in 1.5% of provisional 
1-stent patients and 3.3% of planned 2-stent patients 
(P=0.16). Dual antiplatelet therapy at 3 years was used in 
61.8% and 57.2% of patients in the provisional 1-stent 
and planned 2-stent groups, respectively (P=0.34).
Outcomes According to Distal LM Side 
Branch Involvement
Angiographic core laboratory analysis was performed in 
524 (99.1%) of the 529 patients with distal LM bifur-
cation disease. Among these 524 patients, both LM 
major side branches (LAD and LCX) had an ostial DS 
≥50% in 182 cases (34.7%); a provisional 1-stent ver-
sus a planned 2-stent approach was used in 77 (42.3%) 
and 105 (57.7%) of these patients, respectively. Among 
the other 342 (65.3%) patients without an ostial DS 
of ≥50% in both LM side branches, 264 (77.2%) and 
78 (22.8%) were treated with a provisional 1-stent ver-
sus a planned 2-stent approach, respectively. Among 
patients undergoing a provisional approach, a bailout 
stent was required in 22 (28.6%) of those with and 
32 (12.1%) of those without ostial involvement of 
both side branches (P=0.0005). As shown in Tables 4 
and 5 and Figure 2, in patients with distal LM bifurca-
tion disease that did not involve the ostia of both side 
branch vessels, the 3-year occurrence of death, MI, or 
stroke was significantly lower among patients under-
going provisional 1-stent versus planned 2-stent PCI 
(13.8% versus 23.3%; multivariable-adjusted hazard 
Table 3. Thirty-Day and 3-Year Clinical Outcomes According to the Planned Stent Approach in 
Patients With Left Main Distal Bifurcation Disease
 
Provisional 1-Stent 
(n=344)
Planned 2-Stent 
(n=185) P Value
30-day adverse events
  Death 0.9% (3) 2.7% (5) 0.10
   Cardiovascular death 0.9% (3) 2.7% (5) 0.10
  Myocardial infarction 4.4% (15) 6.5% (12) 0.29
  Stroke 0.3% (1) 1.6% (3) 0.09
  Any IDR 0.9% (3) 1.1% (2) 0.81
  LM complex* IDR 0.9% (3) 0.5% (1) 0.68
  Any definite or probable stent thrombosis 0.6% (2) 1.6% (3) 0.24
  LM definite or probable stent thrombosis 0.6% (2) 1.6% (3) 0.24
  Death, myocardial infarction, or stroke 5.2% (18) 8.7% (16) 0.13
  Death, myocardial infarction, stroke, or IDR 5.2% (18) 8.7% (16) 0.13
3-year adverse events
  Death 6.8% (23) 11.0% (20) 0.08
   Cardiovascular death 3.3% (11) 8.3% (15) 0.01
  Myocardial infarction 7.7% (26) 12.8% (23) 0.06
  Stroke 1.8% (6) 3.4% (6) 0.24
  Any IDR 12.0% (40) 16.7% (29) 0.14
  LM complex* IDR 7.2% (24) 16.3% (28) 0.001
  Any definite or probable stent thrombosis 1.5% (5) 3.3% (6) 0.16
   Definite 0.9% (3) 1.1% (2) 0.78
   Probable 0.6% (2) 2.2% (4) 0.10
  LM definite or probable stent thrombosis 1.5% (5) 2.8% (5) 0.29
   Definite 0.9% (3) 1.1% (2) 0.88
   Probable 0.6% (2) 1.6% (3) 0.78
  Death, myocardial infarction, or stroke 14.1% (48) 20.7% (38) 0.04
  Death, myocardial infarction, stroke, or IDR 22.2% (76) 29.6% (54) 0.055
Values are Kaplan-Meier estimated rates % (n events). IDR indicates ischemia-driven revascularization; and 
LM, left main coronary artery.
*The LM complex consists of the distal LM, the ostial left anterior descending artery, and the ostial left 
circumflex coronary artery.
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ratio, 0.53; 95% CI, 0.29–0.95; P=0.03). In compari-
son, among patients with distal LM bifurcation disease 
that did involve the ostia of both side branch vessels, 
no significant differences in 3-year outcomes between 
the provisional 1-stent and planned 2-stent methods 
were observed. Similarly, all-cause mortality was mar-
ginally lower in patients with distal LM bifurcation dis-
ease that did not involve both ostial side branch vessels 
treated with a provisional 1-stent approach versus a 
planned 2-stent approach (6.1% versus 13.0%; hazard 
ratio, 0.46; 95% CI, 0.21–1.01; log-rank P=0.04; Cox 
P=0.053), whereas survival rates were similar with both 
techniques in distal LM bifurcations with involvement 
of both ostial side branches (Table 5; Figure 2).
DISCUSSION
Among patients undergoing distal LM bifurcation PCI 
in the EXCEL trial, important differences in bifurcation 
anatomy, procedural methods, and outcomes were 
observed in those treated with a provisional 1-stent 
versus a planned 2-stent strategy. Although early out-
comes were similar with the 1-stent provisional and 
planned 2-stent techniques, at 3-year follow-up, the 
rates of cardiovascular death, MI, IDR of the LM com-
plex, and the composite primary end point of death, MI, 
or stroke were more common with a planned 2-stent 
strategy, differences that persisted after multivariable 
adjustment for differences in clinical risk factors and 
coronary anatomy. These outcomes were importantly 
conditioned by whether both major side branches of 
the distal LM bifurcation were or were not involved. 
Specifically, all-cause mortality was lower and event-
free survival was superior with a 1-stent provisional 
compared with a planned 2-stent technique in distal LM 
bifurcation lesions in which both major side branches 
were not involved (ie, when the DS within 3 mm of the 
distal LM bifurcation was <50% by angiographic core 
laboratory analysis in at least 1 major side branch). In 
contrast, if both distal LM major side branches had an 
ostial DS ≥50%, mortality and event-free survival at 3 
years were similar in patients treated with a provisional 
1-stent and planned 2-stent technique.
Most patients randomized to PCI in the EXCEL 
trial had distal LM bifurcation or trifurcation disease, 
the majority of whom were treated with an intended 
A B
Figure 1. Time-to-first event curves in patients with distal left main bifurcation disease.  
Patients were treated with a provisional 1-stent approach (blue curves) or a planned routine 2-stent approach (red curves). A, Time-to-first occurrence of death, 
myocardial infarction (MI), or stroke (the primary end point); (B) Time-to-first occurrence of death, MI, stroke, or ischemia-driven revascularization (IDR; the 
major secondary 3-year end point). For each of the 2 major 3-year end points, event rates were higher for patients treated with the planned routine 2-stent 
approach. HR indicates hazard ratio.
Table 4. Multivariable Correlates of the 3-Year Primary End Point of 
Death, Myocardial Infarction, or Stroke
Variable
Adjusted HR 
[95% CI] P Value
All patients
  Provisional 1-stent vs planned 2-stent 
technique
0.55 [0.35–0.88] 0.01
  Age (per year) 1.04 [1.01–1.07] 0.006
  Male sex 0.61 [0.37–1.01] 0.055
Both LM ostial side branches with DS ≥50%*
  Provisional 1-stent vs planned 2-stent 
technique
0.86 [0.39–1.88] 0.70
  Age (per year) 1.05 [1.00–1.10] 0.045
  Recent myocardial infarction† 0.28 [0.07–1.20] 0.09
  Creatinine clearance <60 mL/min 2.47 [0.96–6.32] 0.06
  Hypertension, medically treated 0.52 [0.24–1.11] 0.09
0 or 1 LM ostial side branches with DS ≥50%*
  Provisional 1-stent vs planned 2-stent 
technique
0.53 [0.29–0.95] 0.03
  Age (per year) 1.03 [1.00–1.06] 0.08
DS indicates diameter stenosis; HR, hazard ratio; and LM, left main 
coronary artery.
*Angiographic core laboratory measure.
†Within 7 days before randomization.
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provisional 1-stent approach and with intravascular 
ultrasound guidance. These practices are consistent 
with registry reports demonstrating the increasing use 
over time of the provisional approach and imaging 
guidance during LM intervention, reflecting emerging 
evidence.12,15,16 Nevertheless, a planned 2-stent tech-
nique is often necessary in cases in which the disease 
in both side branches is severe or when marked side 
branch angulation may compromise future access. As 
evidenced in this trial, a provisional 1-stent strategy was 
preferentially (but not exclusively) selected for patients 
with noncomplex bifurcation disease. The rate of and 
scenarios for use of a planned 2-stent approach, how-
ever, are operator dependent, and the relative out-
comes of a provisional 1-stent versus planned 2-stent 
technique according to bifurcation lesion complexity 
continue to be debated. Other uncertainties include 
whether and when side branch treatment is necessary 
during provisional treatment and the optimal technique 
to select when a second stent is required either for pro-
visional bailout use or during a routine 2-stent case.
Such uncertainties were reflected in the contempo-
rary EXCEL trial, in which some general recommenda-
tions were provided, but ultimate procedural decisions 
were left to operator discretion. Although approxi-
mately two-thirds of all distal LM bifurcations under-
going PCI were treated with a provisional approach, a 
planned 2-stent technique was chosen more commonly 
when both major side branches had ostial involvement. 
Even when angiographic core laboratory analysis con-
firmed that both side branches were involved, a pro-
visional 1-stent approach was still chosen in ≈42% of 
B
A
Figure 2. Three-year outcomes among patients with versus without involvement of the major side branch of the left main complex.  
A, The composite rate of death, myocardial infarction (MI), or stroke; (B) all-cause mortality. Event-free survival was lower and mortality was higher for the provi-
sional 1-stent technique compared with the planned 2-stent technique in patients without major ostial involvement of both side branches of the distal left main (LM) 
bifurcation, but not when both side branches were diseased (ostial diameter stenosis ≥50%). DS indicates diameter stenosis; HR, hazard ratio; and SB, side branch.
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cases, suggesting differences in operator assessment of 
the angiographic severity and complexity of disease or 
procedural comfort with bailout techniques. Conversely, 
when both side branches did not have major involve-
ment (according to the core laboratory), planned 2-stent 
treatment was still undertaken in ≈23% of cases, per-
haps reflecting challenges in visual assessment of the LM 
bifurcation, additional downstream disease in the LCX, 
clinical equipoise, or other factors. Moreover, despite 
evidence suggesting the infrequent need for side branch 
intervention based on published data for angiographic 
or fractional flow reserve assessment17,18 and evidence 
that discourage routine side branch postdilation in non-
LM bifurcation provisional stenting,19 in the present 
study, treatment of the LM side branch was common 
with the provisional technique (most often with balloon 
angioplasty alone). Moreover, bailout stenting during 
the provisional approach was not uncommon (per-
formed in ≈1 in 6 cases), although it was needed more 
frequently when the second major side branch (usually 
the LCX) had versus did not have an ostial lesion with 
DS ≥50% (28.6% versus 12.1%, respectively). The high 
rate of intervention in the side branch even when the 
provisional approach was undertaken likely reflects the 
fact that the LCX lumen in cases with a narrow bifur-
cation angle is often compromised after main branch 
stenting because of carina shift.20 However, side branch 
fractional flow reserve was rarely performed in EXCEL, 
which otherwise may have provided reassurance to not 
dilate or stent the side branch in provisional cases.
The excellent 30-day and 3-year results after PCI 
of distal LM bifurcation disease in EXCEL reflect the 
improved outcomes that can be achieved with evero-
limus-eluting stents, use of intravascular ultrasound 
guidance in most cases, and operators with advanced 
technical skills and ability to select cases appropriately. 
These favorable results notwithstanding, the 3-year 
rates of cardiovascular death, LM complex IDR, and the 
primary end point of death, MI, or stroke were signifi-
cantly more common with a planned 2-stent treatment 
strategy than with a provisional 1-stent strategy, and 
stent thrombosis and MI rates tended to be higher, 
suggesting room for improvement in technique, stent 
properties, and adjunctive technologies. In most prior 
studies of PCI for non-LM bifurcation disease, 2-stent 
treatment has been associated with higher rates of peri-
procedural MI and stent thrombosis.5–8 Observational 
studies of distal LM bifurcation PCI also have reported 
higher rates of cardiovascular death, MI, target lesion 
revascularization, and stent thrombosis with 2-stent 
approaches.21,22 The higher risks associated with 2-stent 
methods may relate to side branch stent underexpan-
sion23 and overlying layers of bifurcating stents.21 The 
relative outcomes of a planned 2-stent strategy ver-
sus a provisional 1-stent approach may depend on the 
bifurcation angle24 and complexity of disease being 
treated. The DEFINITION study (Definitions and Impact 
of Complex Bifurcation Lesions on Clinical Outcomes 
After Percutaneous Coronary Intervention Using Drug-
Eluting Stents) reported lower individual rates of car-
diac death and MI in complex LM bifurcation disease 
(Medina 1,1,1 or 0,1,1) treated with 2 stents compared 
with a provisional strategy.25 In EXCEL, the 3-year clini-
cal event rates with planned 2-stent use compared with 
the provisional approach were comparable if both LM 
side branches had significant ostial disease but were 
inferior (including higher rates of death) if one or both 
major side branch had an ostial DS <50%. When apply-
ing DEFINITION25 trial criteria of LM complexity to EXCEL 
patients with true bifurcation lesions, overall no signifi-
cant differences in outcomes were observed between 
treatment strategy and LM complexity except for higher 
Table 5. Three-Year Outcomes of Distal Left Main Bifurcation Treatment According to Lesion Complexity and Technique Strategy
Angiographic Core 
Laboratory Classification
Both LM Side Branches With Ostial DS ≥50% 0 or 1 LM Side Branches With Ostial DS ≥50%
Provisional 
1-Stent (n=77)
Planned 
2-Stent (n=105)
Hazard Ratio  
[95% CI]
Provisional 
1-Stent (n=246)
Planned 
2-Stent (n=78)
Hazard Ratio  
[95% CI]
Death, MI, or stroke 14.3% (11) 19.2% (20) 0.71 [0.34–1.48] 13.8% (36) 23.3% (18) 0.56 [0.32–0.99]
Death, MI, stroke, or IDR 26.0% (20) 29.9% (31) 0.82 [0.47–1.44] 21.0% (55) 29.8% (23) 0.68 [0.42–1.10]
  Death 9.1% (7) 9.7% (10) 0.90 [0.34–2.36] 6.1% (16) 13.0% (10) 0.46 [0.21–1.01]
   Cardiovascular 4.1% (3) 7.8% (8) 0.49 [0.13–1.83] 3.1% (8) 9.1% (7) 0.33 [0.12–0.91]
  MI 6.6% (5) 13.6% (14) 0.47 [0.17–1.31] 7.8% (20) 12.1% (9) 0.64 [0.29–1.40]
  Stroke 0% (0) 2.0% (2) … 2.4% (6) 5.3% (4) 0.42 [0.12–1.50]
  IDR 14.7% (11) 19.3% (19) 0.72 [0.34–1.52] 10.9% (28) 13.8% (10) 0.80 [0.39–1.65]
   LM complex IDR 6.7% (5) 18.5% (18) 0.33 [0.12–0.90] 6.2% (16) 14.0% (10) 0.45 [0.20–0.99]
Definite or probable stent 
thrombosis
0% (0) 2.9% (3) … 2.0% (5) 4.0% (3) 0.48 [0.11–2.00]
  LM definite or probable stent 
thrombosis
0% (0) 1.9% (2) … 2.0% (5) 4.0% (3) 0.48 [0.11–2.00]
Values are Kaplan-Meier estimated rates % (n). DS indicates diameter stenosis; IDR, ischemia-driven revascularization; LM, left main coronary artery; and 
MI, myocardial infarction.
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LM target lesion revascularization with a planned 
2-stent technique in noncomplex Medina 1,1,1 or 0,1,1 
lesions (Table I in the Data Supplement).
Although these results are compelling in recommend-
ing a provisional 1-stent approach in most cases in which 
the major side branch is not involved, the outcomes 
of a planned 2-stent approach may vary according to 
the technique used. In the randomized DKCRUSH trial 
(Double Kissing Crush Versus Culotte Stenting for the 
Treatment of Unprotected Distal Left Main Bifurcation 
Lesions)-III and DKCRUSH-V trial, the DK crush 2-stent 
method provided superior clinical outcomes compared 
with both a planned culotte 2-stent technique26,27 and 
a provisional 1-stent strategy27 in patients with true dis-
tal LM bifurcation disease. Unfortunately, DK crush use 
in EXCEL was captured under the general category of 
crush techniques and not selectively recorded; however, 
all crush techniques represented <15% of all planned 
2-stent cases, and thus, DK crush was not widely used 
in EXCEL. The extent to which the overall outcomes of 
EXCEL (and specifically the results in the planned 2-stent 
group) may have been improved with more widespread 
usage of the DK crush technique is unknown. The strat-
egy of a planned 2-stent versus a provisional 1-stent PCI 
technique in complex LM bifurcation disease is the focus 
of the ongoing EBC MAIN study (European Bifurcation 
Club Left Main;  NCT02497014).
Limitations
The EXCEL trial, performed at 126 centers in 17 
countries, reflects the clinical outcomes that may be 
expected from contemporary distal LM bifurcation 
treatment (in the context of a randomized trial) by 
experienced operators; however, the decision to use 
a provisional 1-stent versus a planned 2-stent tech-
nique was not randomized, and despite multivariable 
analysis, differences in outcomes may have been influ-
enced by unmeasured confounders not collected in the 
case report form. The influence of selected procedural 
methods that were not recorded in the database, such 
as proximal optimization technique, also cannot be 
determined. In addition, although EXCEL is the larg-
est LM trial to date and the present analysis was pre-
specified, the study was not statistically powered for 
comparison of outcomes in subgroups. For these rea-
sons, the results should be considered hypothesis gen-
erating. Finally, operator assessment and angiographic 
core laboratory measures of LM bifurcation lesion 
severity, length, and angulation often vary. The present 
analysis was performed principally from the operator’s 
perspective to be relevant to catheterization laboratory 
decisions, although it was supplemented by core labo-
ratory measurements to provide objectivity in assessing 
techniques and outcomes according to whether the 
major side branch was truly diseased.
Conclusions
Among patients undergoing distal LM bifurcation PCI 
with everolimus-eluting stents in the EXCEL trial, dif-
ferences in bifurcation disease complexity influenced 
procedural treatments and outcomes with a provi-
sional 1-stent versus a planned 2-stent strategy. During 
3-year follow-up, rates of cardiac death, IDR of the 
LM complex, and the primary composite end point of 
death, MI, or stroke were significantly increased with 
a planned 2-stent strategy compared with a 1-stent 
provisional technique. However, these differences were 
confined to patients without major ostial involvement 
of both LM side branch vessels. In true LM bifurcation 
lesions in which both side branches had major involve-
ment, no statistically significant difference in outcomes 
between the 1-stent provisional and planned 2-stent 
approaches was observed. These results support a pro-
visional 1-stent strategy in most cases when both distal 
LM side branch vessels are not involved (eg, Medina 
1,0,0; 1,1,0; or 1,0,1). Further studies are required to 
determine the optimal approach to true Medina 1,1,1 
or 0,1,1 distal LM bifurcation lesions.
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